Harpoon Therapeutics, Inc. (NASDAQ:HARP) Receives Average Rating of "Hold" from Brokerages : vimarsana.com

Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Free Report) have received a consensus recommendation of “Hold” from the six analysts that are presently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year […]

Related Keywords

United States , Leerink Partnrs , Northern Trust Corp , Harpoon Therapeutics Inc , Securities Exchange Commission , Citigroup , Sequoia Financial Advisors , Delphia United States Inc , Nasdaq , Charles Schwab Investment Management Inc , Merck Co Inc , Harpoon Therapeutics , Get Free Report , Marketbeat Ratings , Exchange Commission , Schwab Investment Management , Financial Advisors , Get Free , Harpoon Therapeutics Daily , Nasdaq Harp , Harp , Medical , Ratings , Consensus ,